1. United States of America Stocks

  2. •

    Real Estate

  3. •

    REIT - Retail
Agree Realty Corporation

Agree Realty Corporation

ADC
Agree Realty CorporationUS flagNew York Stock Exchange
72.03
USD
-0.65
- -
8.65BMarket Cap
Agree Realty Corporation
ADC
(New York Stock Exchange)

Recent

price

72.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.81
3.14
3.13
3.33
3.6
3.89
4
4.04
4.28
4.62
4.8
5.08
5.46
5.65
6.1
6.49
6.59
Revenue per Share
1.54
0.99
1.63
1.51
1.24
2.17
1.97
2.1
1.81
1.97
1.76
1.8
1.84
1.71
1.8
1.78
1.86
Basic EPS, GAAP
-1.3
-1.21
1.92
2.26
2.35
2.48
2.7
2.98
2.91
3.12
2.76
3.69
4.6
4.11
4.27
4.55
4.59
Free Cash Flow per Basic Share
1.88
1.74
1.6
1.6
1.71
1.83
1.84
2
2.11
2.22
2.24
2.93
2.9
3
3.08
3.14
3.17
Dividend per Share
-1.51
-2.17
-1.91
-1.83
-2.19
-1.57
-1.25
-1.04
-1.34
-1.41
-1.76
-2.21
-2.9
-3.64
-4.65
-5.59
-5.74
Book Value per Share
17.13
15.16
15.95
20.24
20.73
20.94
23.86
25.92
29.88
33.22
39.6
38.51
46.48
43.82
44.22
46.02
44.17
Tangible Book Value per Share
10
10
11
13
15
18
23
28
32
41
52
67
79
95
101
111
114
Basic Weighted Avg Shares
27
30
35
44
54
70
92
112
137
187
249
339
430
537
617
718
750
Sales/Revenue/Turnover
54.57
52.65
55.95
58.41
57.71
57.33
56.44
56.46
54.93
54.78
52
52.19
49.75
48.32
48.29
48.29
48.31
Operating Margin (%)
6
7
8
9
11
16
23
32
44
59
83
120
167
209
240
276
289
Depreciation Expense
15
10
18
20
18
39
45
58
58
80
91
122
152
170
189
204
219
Net Income, GAAP
- -
- -
- -
- -
- -
- -
0.33
0.38
0.87
0.66
1.17
1.92
1.83
1.68
2.22
0.84
0.64
Effective Tax Rate (%)
54.94
31.56
52.13
45.21
34.52
55.77
49.29
52.11
42.42
42.71
36.76
36.03
35.47
31.62
30.66
28.45
29.25
Profit Margin (%)
-5
-6
-4
8
-2
-3
24
43
33
-5
-60
12
-11
-29
-31
-28
-25
Working Capital
100
119
161
158
222
317
431
550
748
899
1,254
1,721
1,977
2,448
2,832
3,355
3,755
LT Debt
167
162
198
292
356
454
686
911
1,238
1,692
2,526
3,419
4,630
5,200
5,511
6,271
6,239
Total Equity
5.54
5.27
5.23
5.89
5.87
5.81
5.37
4.81
4.29
4.36
3.9
3.79
3.53
3.58
3.64
3.83
3.86
Return on Invested Capital (%)
16.78
10.72
13.18
15.41
15.09
19.61
16.41
15.78
13.01
13.53
11.91
10.81
11.17
11.86
12.26
12.38
12.04
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
3,362
3,295
3,693
LT Finance Leases
57
60
62
Preferred Equity and Hybrid Capital
175
175
175
Shares Outstanding
114
120
120
Market Capitalization
7,662
7,973
8,586

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
134
143
161
Cash, Cash Equivalents & STI
14
16
25
Accounts Receivable, Net
118
122
130
Inventories
- -
- -
- -
Total Current Liabilities
192
172
186
Payables & Accruals
192
172
186
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
30.87%
20.57%
13.8%
Free Cash Flow
28.79%
30.9%
16.71%
Net Income, GAAP
18.56%
17.86%
8.01%
Sales/Revenue/Turnover
26.44%
23.89%
16.42%
Total Cash Common Dividend
27.15%
25.63%
12.2%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
149
153
154
161
617
2025
169
176
183
190
718
2026
201
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.43
0.53
0.42
0.42
1.8
2025
0.42
0.43
0.45
0.47
1.78
2026
0.5
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.76
0.77
0.77
0.78
3.08
2025
0.78
0.78
0.78
0.8
3.14
2026
0.81
- -
- -
- -
- -
Similar Companies
CapitaLand Integrated Commercial Trust (CPAMF)
Primaris Real Estate Investment Trust (PMZ-UN.TO)
NewRiver REIT plc (NRR.L)
NewRiver REIT plc (NRWRF)
Ally Freehold And Leasehold Real Estate Investment Trust (ALLY.BK)
Capital & Counties Properties PLC (CAPC.L)
Business
Agree Realty Corporation (NYSE: ADC), a fully integrated, self-administered and self-managed real estate investment trust founded in 1971 and headquartered in Royal Oak, Michigan, acquires, develops, owns and manages single-tenant retail properties net leased on a long-term basis primarily to investment-grade national and regional omni-channel retailers including Walmart, Advance Auto Parts, Dollar General, AutoZone, Gerber Collision, CVS, Burlington, Dollar Tree, Best Buy, Academy Sports, and Academy Sports; as of September 30, 2025, the portfolio comprises 2,603 properties containing approximately 54 million square feet of gross leasable area located across all 50 U.S. states, with 67% of annualized base rents derived from investment-grade tenants and 10.9% from ground leases. The company operates through acquisition, ground-up development, and its Developer Funding Platform, targeting properties in 28 retail sectors with a focus on stable, fee-simple ownership and weighted-average lease terms exceeding 10 years. In 2024, Agree Realty executed $951 million in total real estate investments including $867 million in 242 acquisitions at a 7.5% weighted-average cap rate (73.3% investment-grade in Q4), raised approximately $1.1 billion in forward equity through public offerings and its at-the-market program, closed a $350 million 5.5-year delayed draw term loan in November 2025, and strengthened liquidity to over $2.0 billion with no material debt maturities until 2028; for 2025, it projects $1.1 billion to $1.3 billion in investment volume representing a 26% increase at the midpoint.

Company News

APIChat

  • prnewswire.com

    ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • gurufocus.com

    Camizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6

  • seekingalpha.com

    Agree Realty Is Becoming More And More Attractive, But I'm Not Buying Yet

  • gurufocus.com

    Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

  • seekingalpha.com

    U.S. REIT At-The-Market Activity Dips In Q1 2026

  • prnewswire.com

    Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload

  • zacks.com

    Merck's ADC Candidate Meets Goals in Endometrial Cancer Study

  • newsfilecorp.com

    Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities

  • gurufocus.com

    ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer

  • seekingalpha.com

    Whitehawk Therapeutics: 'Hold' On Name Change And Next Generation PTK7 ADC Targeting

  • gurufocus.com

    Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease

  • businesswire.com

    Agree Realty Declares Monthly Common and Preferred Dividends

  • globenewswire.com

    Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

  • globenewswire.com

    InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China

  • businesswire.com

    Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program

  • seekingalpha.com

    ADC Therapeutics: 'Strong Buy' With 2 Shots On Goal For ZYNLONTA In R/R DLBCL

  • prnewswire.com

    ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates

  • seekingalpha.com

    Agree Realty: Bigger Investments, Stronger Growth Amid Uncertainty Puts Them In A Different League

  • prnewswire.com

    ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

  • globenewswire.com

    Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights